Visa Limits Pose Threat to Medical Science - Diverse Health

Higher Education News and Jobs

Visa Limits Pose Threat to Medical Science

Email
   
        


by Doni Bloomfield

Boston/London: From tiny start-ups to global giants, the companies that sustain the $324 billion US biotech industry are increasingly alarmed as President Donald Trump considers following his controversial travel ban with restrictions on skilled foreign immigrants.

To crank out discoveries, US biotech firms such as Amgen Inc. and Gilead Sciences Inc., as well as overseas companies with stateside operations, rely on the world’s best scientists and lower-level researchers with scarce expertise.

Read More

Comments

Print Friendly

Related Articles

Health Disparities Can Be Skin Deep About half of patients will have skin of color by 2050, the U.S. Census Bureau projects. Of the many ways this demographic change will affect American society, there is one medical implication that is not widely appreciated. Dermatologists and the pr...
Obamacare Marketplaces Aren’t Collapsing, but They Aren’t Thriving Typically by August, the state of the upcoming Obamacare enrollment season is pretty evident – that is, what health insurance rates will look like and how many insurers will participate in the marketplaces created under the Affordable Care Act. But n...
Trump Stresses Law Enforcement in Opioid Crisis President Trump emphasized the need for stepped-up law enforcement to combat the nation’s opioid problem Tuesday, an approach that is at odds with a report released last week by the special commission he appointed to address abuse. “Strong law enf...
Study: Exposure to Violence Increases Obesity Risk in Teens Teens consumed more unhealthy foods and beverages on days they were exposed to violence, and suffered from fatigue due to poor sleep the next day, according to a new study by Duke researchers. Those behaviors, especially increased soda consumption, a...